Initial research suggest that the compound – a dual activator of incretin and a related hormone receptors – may provide a substantial advance in weight reduction efforts . Beyond existing therapies, the peptide shows to affect appetite and calorie expenditure by means of separate pathways . Although further investigation is essential, current